Apnimed to Present Data on Drug Candidate for Sleep Apnea
Data from Apnimed’s MARIPOSA phase 2b trial of its drug candidate for OSA will be featured at the ATS 2023 International Conference.
Source: sleepreviewmag.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Inter Scorer Variability. Real-time updates on events, politics, business and more.